发明名称 HETEROCYCLIC COMPOUND
摘要 Provided is a heterocyclic compound having an ROR³t inhibitory activity. A compound represented by the formula (I): wherein ring A is an optionally substituted cyclic group, Q is a bond, optionally substituted C 1-10 alkylene, optionally substituted C 2-10 alkenylene, or optionally substituted C 2-10 alkynylene, R 1 is a substituent, ring B is a thiazole ring, an isothiazole ring or a dihydrothiazole ring, each of which is optionally further substituted by a substituent in addition to R 2 , and R 2 is an optionally substituted cyclyl-carbonyl-C 1-6 alkyl group, an optionally substituted aminocarbonyl-C 1-6 alkyl group, an optionally substituted cyclyl-C 1-6 alkyl group, an optionally substituted cyclyl-C 1-6 alkylamino-carbonyl group, an optionally substituted aminocarbonyl-C 2-6 alkenyl group, an optionally substituted C 1-6 alkylcarbonylamino-C 1-6 alkyl group, an optionally substituted cyclyl-aminocarbonyl group, an optionally substituted cyclyl-carbonyl group or an optionally substituted non-aromatic heterocyclic group, or a salt thereof.
申请公布号 EP2738170(A4) 申请公布日期 2014.12.31
申请号 EP20120820108 申请日期 2012.07.27
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人 YAMAMOTO, SATOSHI;SHIRAI, JUNYA;OCHIDA, ATSUKO;FUKASE, YOSHIYUKI;TOMATA, YOSHIHIDE;SATO, AYUMU;MIURA, SHOTARO;YONEMORI, KAZUKO;KOYAMA, RYOKICHI
分类号 C07D417/04;A61K31/427;A61K31/438;A61K31/4439;A61K31/454;A61K31/4725;A61K31/496;A61K31/497;A61K31/5377;A61K31/541;A61K31/551;A61K31/553;A61P1/04;A61P1/16;A61P1/18;A61P3/10;A61P5/16;A61P7/00;A61P7/06;A61P9/00;A61P11/00 主分类号 C07D417/04
代理机构 代理人
主权项
地址